Armata Pharmaceuticals to Participate in Two Upcoming Investor Conferences

MARINA DEL REY, Calif.: MARINA DEL REY, Calif., Feb. 17, 2022 /PRNewswire/ — Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on pathogen-specific bacteriophage therapeutics for antibiotic-resistant and difficult-to-treat bacterial infections, today announced that the Company will participate in two upcoming investor conferences. Details…